1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol

C130H183N23O19 — CID 158049923

IUPAC1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol
SMILESCNCC(O)COc1cccc(-c2nc(C[C@@H]3CCOC3)c(C)c(C(=O)N(C)CC3CCOCC3)n2)c1.CNCC(O)COc1cccc(-c2nc(C[C@@H]3CCOC3)c(C)c(N3CCC(O)CC3)n2)c1.CNCC(O)COc1cccc(-c2nc(C[C@@H]3CCOC3)c(C)c(N3CCC[C@@H](O)C3)n2)c1.CNCC(O)COc1cccc(-c2nc(C[C@@H]3CCOC3)c(C)c(N3CCn4ccnc4C3)n2)c1.CNCC(O)COc1cccc(-c2nc(N3CCCCC3)cc(N(C3CC3)[C@@H]3CCOC3)n2)c1
InChIInChI=1S/C28H40N4O5.C26H34N6O3.C26H37N5O3.2C25H36N4O4/c1-19-25(13-21-9-12-36-17-21)30-27(22-5-4-6-24(14-22)37-18-23(33)15-29-2)31-26(19)28(34)32(3)16-20-7-10-35-11-8-20;1-18-23(12-19-6-11-34-16-19)29-25(20-4-3-5-22(13-20)35-17-21(33)14-27-2)30-26(18)32-10-9-31-8-7-28-24(31)15-32;1-27-16-22(32)18-34-23-7-5-6-19(14-23)26-28-24(30-11-3-2-4-12-30)15-25(29-26)31(20-8-9-20)21-10-13-33-17-21;1-17-23(11-18-8-10-32-15-18)27-24(28-25(17)29-9-4-6-20(30)14-29)19-5-3-7-22(12-19)33-16-21(31)13-26-2;1-17-23(12-18-8-11-32-15-18)27-24(28-25(17)29-9-6-20(30)7-10-29)19-4-3-5-22(13-19)33-16-21(31)14-26-2/h4-6,14,20-21,23,29,33H,7-13,15-18H2,1-3H3;3-5,7-8,13,19,21,27,33H,6,9-12,14-17H2,1-2H3;5-7,14-15,20-22,27,32H,2-4,8-13,16-18H2,1H3;3,5,7,12,18,20-21,26,30-31H,4,6,8-11,13-16H2,1-2H3;3-5,13,18,20-21,26,30-31H,6-12,14-16H2,1-2H3/t21-,23?;19-,21?;21-,22?;18-,20+,21?;18-,21?/m00100/s1
InChIKeyFJIVDOMBKPDCIV-OPYONCJQSA-N
MW2372.04 g/mol
LogP11.45
Rot. Bonds48

About 1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol

1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol (PubChem CID 158049923) has the molecular formula C130H183N23O19 and a molecular weight of 2372.04 g/mol. Its IUPAC name is 1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol.

Molecular Properties

Compound Name1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol
PubChem CID158049923
Molecular FormulaC130H183N23O19
Molecular Weight2372.04 g/mol
Exact Mass2370.41
IUPAC Name1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol
SMILESCNCC(O)COc1cccc(-c2nc(C[C@@H]3CCOC3)c(C)c(C(=O)N(C)CC3CCOCC3)n2)c1.CNCC(O)COc1cccc(-c2nc(C[C@@H]3CCOC3)c(C)c(N3CCC(O)CC3)n2)c1.CNCC(O)COc1cccc(-c2nc(C[C@@H]3CCOC3)c(C)c(N3CCC[C@@H](O)C3)n2)c1.CNCC(O)COc1cccc(-c2nc(C[C@@H]3CCOC3)c(C)c(N3CCn4ccnc4C3)n2)c1.CNCC(O)COc1cccc(-c2nc(N3CCCCC3)cc(N(C3CC3)[C@@H]3CCOC3)n2)c1
InChIInChI=1S/C28H40N4O5.C26H34N6O3.C26H37N5O3.2C25H36N4O4/c1-19-25(13-21-9-12-36-17-21)30-27(22-5-4-6-24(14-22)37-18-23(33)15-29-2)31-26(19)28(34)32(3)16-20-7-10-35-11-8-20;1-18-23(12-19-6-11-34-16-19)29-25(20-4-3-5-22(13-20)35-17-21(33)14-27-2)30-26(18)32-10-9-31-8-7-28-24(31)15-32;1-27-16-22(32)18-34-23-7-5-6-19(14-23)26-28-24(30-11-3-2-4-12-30)15-25(29-26)31(20-8-9-20)21-10-13-33-17-21;1-17-23(11-18-8-10-32-15-18)27-24(28-25(17)29-9-4-6-20(30)14-29)19-5-3-7-22(12-19)33-16-21(31)13-26-2;1-17-23(12-18-8-11-32-15-18)27-24(28-25(17)29-9-6-20(30)7-10-29)19-4-3-5-22(13-19)33-16-21(31)14-26-2/h4-6,14,20-21,23,29,33H,7-13,15-18H2,1-3H3;3-5,7-8,13,19,21,27,33H,6,9-12,14-17H2,1-2H3;5-7,14-15,20-22,27,32H,2-4,8-13,16-18H2,1H3;3,5,7,12,18,20-21,26,30-31H,4,6,8-11,13-16H2,1-2H3;3-5,13,18,20-21,26,30-31H,6-12,14-16H2,1-2H3/t21-,23?;19-,21?;21-,22?;18-,20+,21?;18-,21?/m00100/s1
InChIKeyFJIVDOMBKPDCIV-OPYONCJQSA-N
XLogP11.45
TPSA486.52 Ų
H-Bond Donors12
H-Bond Acceptors41
Rotatable Bonds48
Heavy Atoms172
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002372.04
LogP ≤ 511.45
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1041

Analyze 1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol?
The IUPAC name of 1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol (CID 158049923) is 1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol.
What is the SMILES notation for 1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol?
The canonical SMILES for 1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol is CNCC(O)COc1cccc(-c2nc(C[C@@H]3CCOC3)c(C)c(C(=O)N(C)CC3CCOCC3)n2)c1.CNCC(O)COc1cccc(-c2nc(C[C@@H]3CCOC3)c(C)c(N3CCC(O)CC3)n2)c1.CNCC(O)COc1cccc(-c2nc(C[C@@H]3CCOC3)c(C)c(N3CCC[C@@H](O)C3)n2)c1.CNCC(O)COc1cccc(-c2nc(C[C@@H]3CCOC3)c(C)c(N3CCn4ccnc4C3)n2)c1.CNCC(O)COc1cccc(-c2nc(N3CCCCC3)cc(N(C3CC3)[C@@H]3CCOC3)n2)c1.
What is the InChIKey of 1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol?
The InChIKey is FJIVDOMBKPDCIV-OPYONCJQSA-N. The full InChI is InChI=1S/C28H40N4O5.C26H34N6O3.C26H37N5O3.2C25H36N4O4/c1-19-25(13-21-9-12-36-17-21)30-27(22-5-4-6-24(14-22)37-18-23(33)15-29-2)31-26(19)28(34)32(3)16-20-7-10-35-11-8-20;1-18-23(12-19-6-11-34-16-19)29-25(20-4-3-5-22(13-20)35-17-21(33)14-27-2)30-26(18)32-10-9-31-8-7-28-24(31)15-32;1-27-16-22(32)18-34-23-7-5-6-19(14-23)26-28-24(30-11-3-2-4-12-30)15-25(29-26)31(20-8-9-20)21-10-13-33-17-21;1-17-23(11-18-8-10-32-15-18)27-24(28-25(17)29-9-4-6-20(30)14-29)19-5-3-7-22(12-19)33-16-21(31)13-26-2;1-17-23(12-18-8-11-32-15-18)27-24(28-25(17)29-9-6-20(30)7-10-29)19-4-3-5-22(13-19)33-16-21(31)14-26-2/h4-6,14,20-21,23,29,33H,7-13,15-18H2,1-3H3;3-5,7-8,13,19,21,27,33H,6,9-12,14-17H2,1-2H3;5-7,14-15,20-22,27,32H,2-4,8-13,16-18H2,1H3;3,5,7,12,18,20-21,26,30-31H,4,6,8-11,13-16H2,1-2H3;3-5,13,18,20-21,26,30-31H,6-12,14-16H2,1-2H3/t21-,23?;19-,21?;21-,22?;18-,20+,21?;18-,21?/m00100/s1.
What are the key properties of 1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol?
1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol has a molecular weight of 2372.04 g/mol, XLogP of 11.45, 48 rotatable bonds, 12 hydrogen bond donors, and 41 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-[4-[cyclopropyl-[(3R)-oxolan-3-yl]amino]-6-piperidin-1-ylpyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;1-[3-[4-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol;2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-N,5-dimethyl-N-(oxan-4-ylmethyl)-6-[[(3R)-oxolan-3-yl]methyl]pyrimidine-4-carboxamide;1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-4-ol;(3R)-1-[2-[3-[2-hydroxy-3-(methylamino)propoxy]phenyl]-5-methyl-6-[[(3R)-oxolan-3-yl]methyl]pyrimidin-4-yl]piperidin-3-ol is sourced from PubChem (CID 158049923), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).